US Stock MarketDetailed Quotes

GSK GlaxoSmithKline

Watchlist
  • 40.650
  • -0.460-1.12%
Close Jun 14 16:00 ET
  • 40.665
  • +0.015+0.04%
Post 19:58 ET
82.89BMarket Cap14.64P/E (TTM)

GlaxoSmithKline Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GlaxoSmithKline Earnings Date

Currency: GBP

Period

Q1 FY2024 Earnings

May 1, 2024

Revenue(YoY)

7.36B

+5.93%
EPS(YoY)

0.51

-30.41%
Analyst Rating

Buy

Jun 4, 2024

GlaxoSmithKline Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 8.534B--
Jul 31, 20242024/Q2-- / 7.533B--
May 1, 20242024/Q17.363B / 7.060B--
--2023/Q48.052B / 7.621B--
Nov 1, 20232023/Q38.147B / 7.727B--
Jul 26, 20232023/Q27.178B / 6.795B--
Apr 26, 20232023/Q16.951B / 6.580B--
Feb 1, 20232022/Q47.376B / 7.101B--
Nov 2, 20222022/Q37.829B / 7.214B--
Jul 27, 20222022/Q26.929B / 6.906B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 8.534B--
Jul 31, 20242024/Q2-- / 7.533B--
May 1, 20242024/Q17.363B / 7.060B--
--2023/Q48.052B / 7.621B--
Nov 1, 20232023/Q38.147B / 7.727B--
Jul 26, 20232023/Q27.178B / 6.795B--
Apr 26, 20232023/Q16.951B / 6.580B--
Feb 1, 20232022/Q47.376B / 7.101B--
Nov 2, 20222022/Q37.829B / 7.214B--
Jul 27, 20222022/Q26.929B / 6.906B--

Unlock Free Earnings Estimates

GlaxoSmithKline Earnings Reports

  • 6-K: Gsk Makes a Strong Start to 2024 with Improving Outlook for the Year

    May 1 12:34 ET

  • GlaxoSmithKline | 6-K: Glaxosmithkline 2023 Annual Report on Form 20-F

    Mar 5 13:13 ET

  • GlaxoSmithKline | 20-F: Registration statement / Annual report / Transition report

    Mar 5 12:18 ET

  • GlaxoSmithKline | 6-K: Gsk Delivers Strong 2023 Performance and Upgrades Growth Outlooks

    Jan 31 13:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 4, 2024

    Buy

    • Buy

      50.00%

    • Hold

      25.00%

    • Sell

      25.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday+0.07%